- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Delaware Officials Still Don't Know Premium Costs for New Health Insurance Exchange
Officials overseeing Delaware's implementation of the federal health care reform law still don't know what residents will pay for health care coverage under a new state health insurance exchange.
Officials overseeing Delaware’s implementation of the federal health care reform law still don’t know what residents will pay for health care coverage under a new state health insurance exchange.
Officials expect to begin enrolling some 35,000 people in the health insurance exchange starting Oct. 1, for coverage effective Jan. 1, 2014.
But officials said Thursday at a meeting of the Delaware Health Care Commission that they still don’t know how much the premiums for the various insurance plans in the exchange will cost, and that they probably won’t know until enrollment actually begins.
But officials were quick to point out that individuals with incomes up to 400 percent of the federal poverty level will be eligible for premium subsidies in the form of advance tax credits.
Read the full story here: http://wapo.st/1ambWE4
Source: The Washington Post
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More
